{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:30:56Z","timestamp":1777725056627,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,20]]},"DOI":"10.7759\/cureus.42218","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T02:38:57Z","timestamp":1689907137000},"source":"Crossref","is-referenced-by-count":3,"title":["A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome"],"prefix":"10.7759","author":[{"given":"Ammar","family":"Al-Obaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himil","family":"Mahadevia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zain","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto MN","year":"2016","unstructured":"Polizzotto MN, Uldrick TS, Wyvill KM, et al.. Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: prospective characterization of KSHV inflammatory cytokine syndrome (KICS). Clin Infect Dis. 2016, 62:730-738. 10.1093\/cid\/civ996","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199601000-00009","article-title":"Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients","volume":"10","author":"Oksenhendler E","year":"1996","unstructured":"Oksenhendler E, Duarte M, Soulier J, et al.. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996, 10:61-67. 10.1097\/00002030-199601000-00009","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/654798","article-title":"An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without multicentric Castleman disease","volume":"51","author":"Uldrick TS","year":"2010","unstructured":"Uldrick TS, Wang V, O'Mahony D, et al.. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without multicentric Castleman disease. Clin Infect Dis. 2010, 51:350-358. 10.1086\/654798","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00073","article-title":"Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome","volume":"3","author":"Polizzotto MN","year":"2012","unstructured":"Polizzotto MN, Uldrick TS, Hu D, Yarchoan R. Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome. Front Microbiol. 2012, 3:73. 10.3389\/fmicb.2012.00073","journal-title":"Front Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000330","article-title":"Kaposi sarcoma herpesvirus-associated cancers and related diseases","volume":"12","author":"Goncalves PH","year":"2017","unstructured":"Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R. Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr Opin HIV AIDS. 2017, 12:47-56. 10.1097\/COH.0000000000000330","journal-title":"Curr Opin HIV AIDS"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-586800","article-title":"Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease","volume":"124","author":"Uldrick TS","year":"2014","unstructured":"Uldrick TS, Polizzotto MN, Aleman K, et al.. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood. 2014, 124:3544-3552. 10.1182\/blood-2014-07-586800","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-317610","article-title":"High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy","volume":"117","author":"Uldrick TS","year":"2011","unstructured":"Uldrick TS, Polizzotto MN, Aleman K, et al.. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood. 2011, 117:6977-6986. 10.1182\/blood-2010-11-317610","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx196","article-title":"Experience with Kaposi sarcoma herpesvirus inflammatory cytokine syndrome in a large urban HIV clinic in the United States: case series and literature review","volume":"4","author":"Cantos VD","year":"2017","unstructured":"Cantos VD, Kalapila AG, Ly Nguyen M, Adamski M, Gunthel CJ. Experience with Kaposi sarcoma herpesvirus inflammatory cytokine syndrome in a large urban HIV clinic in the United States: case series and literature review. Open Forum Infect Dis. 2017, 4:ofx196. 10.1093\/ofid\/ofx196","journal-title":"Open Forum Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0237","article-title":"Kaposi sarcoma inflammatory cytokine syndrome (KICS): a rare but potentially treatable condition","volume":"22","author":"Karass M","year":"2017","unstructured":"Karass M, Grossniklaus E, Seoud T, Jain S, Goldstein DA. Kaposi sarcoma inflammatory cytokine syndrome (KICS): a rare but potentially treatable condition. Oncologist. 2017, 22:623-625. 10.1634\/theoncologist.2016-0237","journal-title":"Oncologist"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926433","article-title":"A fatal case of Kaposi sarcoma immune reconstitution syndrome (KS-IRIS) complicated by Kaposi sarcoma inflammatory cytokine syndrome (KICS) or multicentric Castleman disease (MCD): a case report and review","volume":"21","author":"Dumic I","year":"2020","unstructured":"Dumic I, Radovanovic M, Igandan O, et al.. A fatal case of Kaposi sarcoma immune reconstitution syndrome (KS-IRIS) complicated by Kaposi sarcoma inflammatory cytokine syndrome (KICS) or multicentric Castleman disease (MCD): a case report and review. Am J Case Rep. 2020, 21:e926433. 10.12659\/AJCR.926433","journal-title":"Am J Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181bc476f","article-title":"Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study","volume":"53","author":"Letang E","year":"2010","unstructured":"Letang E, Almeida JM, Mir\u00f3 JM, et al.. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study. J Acquir Immune Defic Syndr. 2010, 53:589-597. 10.1097\/QAI.0b013e3181bc476f","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.jfas.2019.08.012","article-title":"Kaposi sarcoma inflammatory cytokine syndrome presenting as infection: a case report","volume":"59","author":"Tally T","year":"2020","unstructured":"Tally T, Dretler R, Cain T, Brennan K. Kaposi sarcoma inflammatory cytokine syndrome presenting as infection: a case report. J Foot Ankle Surg. 2020, 59:403-408. 10.1053\/j.jfas.2019.08.012","journal-title":"J Foot Ankle Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.1909","article-title":"Clinical features and outcome in HIV-associated multicentric Castleman's disease","volume":"29","author":"Bower M","year":"2011","unstructured":"Bower M, Newsom-Davis T, Naresh K, et al.. Clinical features and outcome in HIV-associated multicentric Castleman's disease. J Clin Oncol. 2011, 29:2481-2486. 10.1200\/JCO.2010.34.1909","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial","volume":"25","author":"G\u00e9rard L","year":"2007","unstructured":"G\u00e9rard L, B\u00e9rezn\u00e9 A, Galicier L, et al.. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol. 2007, 25:3350-3356. 10.1200\/JCO.2007.10.6732","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.003","article-title":"The role of interleukin-6 in Castleman disease","volume":"32","author":"Yoshizaki K","year":"2018","unstructured":"Yoshizaki K, Murayama S, Ito H, Koga T. The role of interleukin-6 in Castleman disease. Hematol Oncol Clin North Am. 2018, 32:23-36. 10.1016\/j.hoc.2017.09.003","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/167158-a-challenging-case-of-kaposi-sarcoma-inflammatory-cytokine-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:54Z","timestamp":1707508854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/167158-a-challenging-case-of-kaposi-sarcoma-inflammatory-cytokine-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.42218","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}